Clinical Trial Update: Tenofovir Alafenamide in HBV Related Decompensated Liver [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Tenofovir Alafenamide in HBV-related decompensated liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hbv-related Liver Decompensation
• Hepatitis B

Drugs mentioned

• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: HBV | Phase 4 | Status: UNKNOWN